Home / Conditions / Temporomandibular Joint Dysfunction
Temporomandibular Joint Dysfunction: when insurers say no, reviewers often say yes
In 24 published external-review decisions involving temporomandibular joint dysfunction, independent physician reviewers overturned the insurer’s denial 50% of the time.
Published decisions
24
2001–2026
Overturned
50%
12 denials reversed
Most-fought treatments for temporomandibular joint dysfunction
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Botox Injections | 5 | 20% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 17 | 64.7% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 7 | 14.3% |
Typical time to a decision
21 days
Most land between 15 and 21 days
Handled as urgent
8.3%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Physician 1: The patient is a 47-year-old female with chronic pain and temporomandibular joint dysfunction. She has requested authorization and coverage for Botox indicating it has reduced her need for Ultram by 50%. The patient continues to have moderate pain. The Health Plan has denied coverage for Botox therapy on the basis it is considered experimental for treatment of the patient’s medical condition.Review of the medical literature reveals little evidence to support the use of Botox for myofascial pain. The relevant literature mostly involves open label trials and case report series and is quite limited. Furthermore, the submitted clinical information does not provide sufficient detail regarding the patient’s attempts at standard therapy. It appears standard therapy, which may include surgery, is more likely to be effective for this patient than Botox therapy.
Nature of Statutory Criteria/Case Summary: enrollee has requested reimbursement for computed tomography (CT). Findings: The physician reviewer found that the submitted documentation supports the services at issue in this clinical setting. Temporomandibular joint dysfunction is an umbrella term used to describe pain and dysfunction of the muscles and skeletal structures involved in mastication. It is a symptom complex, as opposed to a specific disease or illness, and as much as 20-30% of the entire adult population is affected at some point in their lives. Etiologies range from a simple dental abnormality, such as an uneven dental filling, to significant malformations of the temporomandibular joint. As such, there is considerable variation in the diagnostic evaluation.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Physician 1: The patient is a 35-year-old female with temporomandibular joint dysfunction and associated head and neck pain. Treatment with physical therapy produced significant improvement in symptoms. The submitted evidence does not demonstrate that she has been treated with a combination of dental occlusal splinting, analgesics and physical therapy. Orthotic splinting and occlusal equilibration has not been performed and the patient’s symptoms have recurred.A request has been made for authorization and coverage for an electromyography (EMG).
Nature of Statutory Criteria/Case Summary: The patient requested reimbursement for Botox injections. Temporomandibular joint dysfunction is a term used to describe pain and dysfunction of the muscles of mastication and the temporomandibular joints. The authors of a study explained that temporomandibular disorders have a range of causes and often co-occur with overlapping medical conditions such as headaches, fibromyalgia, and back pain. While there are many treatments available, there is a general lack of evidence for any treatments for temporomandibular disorders, and there is no widely accepted treatment protocol.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for temporomandibular joint dysfunction was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.